Enhanced Biosynthesis of Fatty Acids Contributes to Ciprofloxacin Resistance in Pseudomonas aeruginosa

Antibiotic-resistant Pseudomonas aeruginosa is insensitive to antibiotics and difficult to deal with. An understanding of the resistance mechanisms is required for the control of the pathogen. In this study, gas chromatography–mass spectrometer (GC-MS)-based metabolomics was performed to identify differential metabolomes in ciprofloxacin (CIP)-resistant P. aeruginosa strains that originated from P. aeruginosa ATCC 27853 and had minimum inhibitory concentrations (MICs) that were 16-, 64-, and 128-fold (PA-R16CIP, PA-R64CIP, and PA-R128CIP, respectively) higher than the original value, compared to CIP-sensitive P. aeruginosa (PA-S). Upregulation of fatty acid biosynthesis forms a characteristic feature of the CIP-resistant metabolomes and fatty acid metabolome, which was supported by elevated gene expression and enzymatic activity in the metabolic pathway. The fatty acid synthase inhibitor triclosan potentiates CIP to kill PA-R128CIP and clinically multidrug-resistant P. aeruginosa strains. The potentiated killing was companied with reduced gene expression and enzymatic activity and the returned abundance of fatty acids in the metabolic pathway. Consistently, membrane permeability was reduced in the PA-R and clinically multidrug-resistant P. aeruginosa strains, which were reverted by triclosan. Triclosan also stimulated the uptake of CIP. These findings highlight the importance of the elevated biosynthesis of fatty acids in the CIP resistance of P. aeruginosa and provide a target pathway for combating CIP-resistant P. aeruginosa.

[1]  Jia-xin Zhu,et al.  Glutamine promotes antibiotic uptake to kill multidrug-resistant uropathogenic bacteria , 2021, Science Translational Medicine.

[2]  Peihua Shen,et al.  Elevation of Fatty Acid Biosynthesis Metabolism Contributes to Zhongshengmycin Resistance in Xanthomonas oryzae , 2021, Antibiotics.

[3]  Tiantuo Zhang,et al.  Inactivation of Nitrite-Dependent Nitric Oxide Biosynthesis Is Responsible for Overlapped Antibiotic Resistance between Naturally and Artificially Evolved Pseudomonas aeruginosa , 2021, mSystems.

[4]  Xuan-xian Peng,et al.  Enhanced Biosynthesis of Fatty Acids Is Associated with the Acquisition of Ciprofloxacin Resistance in Edwardsiella tarda , 2021, mSystems.

[5]  N. Lall,et al.  Elucidating the Antimycobacterial Mechanism of Action of Ciprofloxacin Using Metabolomics , 2021, Microorganisms.

[6]  J. Boccard,et al.  Metabotypes of Pseudomonas aeruginosa Correlate with Antibiotic Resistance, Virulence and Clinical Outcome in Cystic Fibrosis Chronic Infections , 2021, Metabolites.

[7]  Xuan-xian Peng,et al.  Synergy of alanine and gentamicin to reduce nitric oxide for elevating killing efficacy to antibiotic-resistant Vibrio alginolyticus , 2021, Virulence.

[8]  Dan Wang,et al.  Mechanisms for Development of Ciprofloxacin Resistance in a Clinical Isolate of Pseudomonas aeruginosa , 2021, Frontiers in Microbiology.

[9]  Xuan-xian Peng,et al.  Na+-NQR Confers Aminoglycoside Resistance via the Regulation of l-Alanine Metabolism , 2020, mBio.

[10]  Fernando García,et al.  Transcriptomic determinants of the response of ST-111 Pseudomonas aeruginosa AG1 to ciprofloxacin identified by a top-down systems biology approach , 2020, Scientific Reports.

[11]  S. Dolan Current Knowledge and Future Directions in Developing Strategies to Combat Pseudomonas aeruginosa Infection. , 2020, Journal of molecular biology.

[12]  Shuo Feng,et al.  Comparative Genomic and Metabolomic Analyses of Two Pseudomonas aeruginosa Strains With Different Antifungal Activities , 2020, Frontiers in Microbiology.

[13]  M. Sommer,et al.  The evolutionary trajectories of P. aeruginosa in biofilm and planktonic growth modes exposed to ciprofloxacin: beyond selection of antibiotic resistance , 2020, npj Biofilms and Microbiomes.

[14]  Xuan-xian Peng,et al.  Reduced ROS-mediated antibiotic resistance and its reverting by glucose in Vibrio alginolyticus. , 2020, Environmental microbiology.

[15]  E. Schneider-Futschik,et al.  Metabolomic Description of Ivacaftor Elevating Polymyxin B Mediated Antibacterial Activity in Cystic Fibrosis Pseudomonas aeruginosa. , 2020, ACS pharmacology & translational science.

[16]  C. Waters,et al.  Triclosan depletes the membrane potential in Pseudomonas aeruginosa biofilms inhibiting aminoglycoside induced adaptive resistance , 2020, bioRxiv.

[17]  Xuan Deng,et al.  Fis Contributes to Resistance of Pseudomonas aeruginosa to Ciprofloxacin by Regulating Pyocin Synthesis , 2020, Journal of bacteriology.

[18]  Xuan-xian Peng,et al.  Identification and innate immunity mechanism of protective immunogens from extracellular proteins of Edwardsiella tarda. , 2019, Fish & shellfish immunology.

[19]  Xuan-xian Peng,et al.  Reduced redox-dependent mechanism and glucose-mediated reversal in gentamicin-resistant Vibrio alginolyticus. , 2019, Environmental microbiology.

[20]  Sławomir Jabłoński,et al.  Metabolomic studies of Pseudomonas aeruginosa , 2019, World Journal of Microbiology and Biotechnology.

[21]  Rajiv Kumar,et al.  Usnic acid modifies MRSA drug resistance through down‐regulation of proteins involved in peptidoglycan and fatty acid biosynthesis , 2019, FEBS open bio.

[22]  A. Oliver,et al.  Epidemiology and Treatment of Multidrug-Resistant and Extensively Drug-Resistant Pseudomonas aeruginosa Infections , 2019, Clinical Microbiology Reviews.

[23]  Jian-ying Zhang,et al.  Glycine, serine and threonine metabolism confounds efficacy of complement-mediated killing , 2019, Nature Communications.

[24]  D. T. Loots,et al.  Fatty Acid Metabolome Extraction from Mycobacterial Cells for GC-MS Metabolomics Analysis. , 2018, Methods in molecular biology.

[25]  W. Patrick,et al.  Mechanisms of ciprofloxacin resistance in Pseudomonas aeruginosa: new approaches to an old problem. , 2019, Journal of medical microbiology.

[26]  B. Glick,et al.  Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and alternative therapeutic strategies. , 2019, Biotechnology advances.

[27]  Xuan-xian Peng,et al.  The depressed central carbon and energy metabolisms is associated to the acquisition of levofloxacin resistance in Vibrio alginolyticus. , 2018, Journal of proteomics.

[28]  M. Sommer,et al.  Evolution of Antibiotic Resistance in Biofilm and Planktonic Pseudomonas aeruginosa Populations Exposed to Subinhibitory Levels of Ciprofloxacin , 2018, Antimicrobial Agents and Chemotherapy.

[29]  Jia-xin Zhu,et al.  Pyruvate cycle increases aminoglycoside efficacy and provides respiratory energy in bacteria , 2018, Proceedings of the National Academy of Sciences.

[30]  Jeffrey Hill,et al.  Pseudomonas aeruginosa develops Ciprofloxacin resistance from low to high level with distinctive proteome changes. , 2017, Journal of proteomics.

[31]  Tao Zhang,et al.  Polyphosphate Kinase Mediates Antibiotic Tolerance in Extraintestinal Pathogenic Escherichia coli PCN033 , 2016, Front. Microbiol..

[32]  N. Høiby,et al.  The phenotypic evolution of Pseudomonas aeruginosa populations changes in the presence of subinhibitory concentrations of ciprofloxacin. , 2016, Microbiology.

[33]  Xuan-xian Peng,et al.  Functional metabolomics: from biomarker discovery to metabolome reprogramming , 2015, Protein & Cell.

[34]  C. Guo,et al.  Exogenous alanine and/or glucose plus kanamycin kills antibiotic-resistant bacteria. , 2015, Cell metabolism.

[35]  Hany M. Yehia,et al.  Studies on Molecular Characterizations of the Outer Membrane Proteins, Lipids Profile, and Exopolysaccharides of Antibiotic Resistant Strain Pseudomonas aeruginosa , 2015, BioMed research international.

[36]  D. Manns,et al.  Bactericidal thurincin H causes unique morphological changes in Bacillus cereus F4552 without affecting membrane permeability. , 2014, FEMS microbiology letters.

[37]  J. Hossain,et al.  The Quest for the Best Metric of Antibiotic Use and Its Correlation with the Emergence of Fluoroquinolone Resistance in Children , 2014, The Pediatric infectious disease journal.

[38]  Laura R. Jarboe,et al.  The damaging effects of short chain fatty acids on Escherichia coli membranes , 2013, Applied Microbiology and Biotechnology.

[39]  I. Vattulainen,et al.  Mechanism for translocation of fluoroquinolones across lipid membranes. , 2012, Biochimica et biophysica acta.

[40]  G. Booker,et al.  Structure, function and selective inhibition of bacterial acetyl-coa carboxylase , 2011, Applied Microbiology and Biotechnology.

[41]  M. Welch,et al.  Mutation of nfxB causes global changes in the physiology and metabolism of Pseudomonas aeruginosa. , 2010, Journal of proteome research.

[42]  R. Hancock,et al.  Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances , 2008, Nature Protocols.

[43]  J. Shepard,et al.  A triclosan-ciprofloxacin cross-resistant mutant strain of Staphylococcus aureus displays an alteration in the expression of several cell membrane structural and functional genes. , 2007, Research in microbiology.

[44]  R. Heath,et al.  Broad Spectrum Antimicrobial Biocides Target the FabI Component of Fatty Acid Synthesis* , 1998, The Journal of Biological Chemistry.

[45]  K. Kim,et al.  Regulation of mammalian acetyl-coenzyme A carboxylase. , 1997, Annual review of nutrition.